You are here: Industry Insights > Biomerica

News List

Biomerica’s 15-Minute COVID-19 Antigen Rapid Test Receives CE Mark americanpharmaceuticalreview
January 20, 2021
Biomerica has received CE Mark for its new COVID-19 Rapid Antigen Test for detection of COVID-19 infection. The Company has already received its first European orders and plans to ship the first part of these orders in the coming weeks.
Biomerica Files for EUA for its COVID-19 Laboratory Antibody Test americanpharmaceuticalreview
June 29, 2020
Biomerica submitted an Emergency Use Authorization (EUA) application to the U.S. Food and Drug Administration (FDA) for an ELISA lab-based serology blood test for the detection of antibodies that identify if a person has been infected with ...
Biomerica Receives CE Mark for 10 Minute COVID-19 Exposure Test americanpharmaceuticalreview
May 08, 2020
Biomerica has received a CE mark and launched a new high-volume production version of its COVID-19 IgG/IgM Rapid Test (a finger prick blood test with results in 10 minutes.
Biomerica Signs Agreements with Mount Sinai Medical School to Scale-up COVID-19 Serological Test americanpharmaceuticalreview
April 07, 2020
Biomerica has signed two separate definitive license agreements with Mount Sinai’s Icahn School of Medicine in New York to license technologies pertaining to a laboratory version serological test ...
Biomerica Begins Shipping Samples of 10 Minute Test for COVID-19 Virus Exposure americanpharmaceuticalreview
March 20, 2020
Biomerica has commenced shipping initial samples of its COVID-19 IgG/IgM Rapid Test (a finger prick blood test with results in 10 minutes that can be performed ...